most effective glp-1 clinical trials outcomes Cardiovascular Effects and Tolerability of Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients Emerging Frontiers in GLP-1 Therapeutics:

While GLP-1-RAs have been shown to lower the risk of serious heart and stroke complications in the general population with type 2 diabetes, their effects on individuals with autoimmune diseases have not been thoroughly investigated

GSH is a tripeptide of L-glutamate, L-cysteine, and glycine

doi: 10.1016/j.mcn.2024.103919, 107 NichollsD

Samms RJ, Christe ME, Collins KA et al (2021) GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice

For people who aren't candidates for medication, can't afford it or prefer to start with lifestyle changes, focusing on GLP-1-supporting foods and habits can meaningfully improve appetite control and metabolic health